Comprehensive genomic testing is beneficial for patients at all stages of lung adenocarcinoma, according to a recent study.
Researchers found an increased number of young-onset pancreatico-biliary cancers, and that race, sex and socioeconomic status impact incidents and outcomes.
In October 2020, a 39-year-old woman presented to Cleveland Clinic Cancer Center with a recurrence of advanced rectal adenocarcinoma. The year before, her disease was diagnosed at another institution as stage III (T3N2M0); it was treated with chemotherapy, chemoradiation and surgery, but unfortunately the cancer recurred very quickly. The patient’s first treatment regimen included eight … Read More
A study presented at the USCAP 2018 Annual Meeting finds that insulinoma-associated protein 1 (INSM1) is a reliable marker for the diagnosis of neuroendocrine lung tumors, including small-cell lung carcinoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Dr. Jordan Reynolds, anatomic and molecular pathologist, discusses a case that illustrates how to diagnose lung cancer on small specimens.